⌕
Alexion Pharmaceuticals · ALXN · Nasdaq
$182.50at last closeTenet 64 · Solid
Compare
$182.50at last closeTenet 64 · Solid

Alexion Pharmaceuticals (ALXN) Stock

Alexion Pharmaceuticals (ALXN) has a Tenet Score of 64 of 100 against 374 Healthcare peers, as of Jul 29, 2026.

Sources Company filings, market prices and computed by Tenet Filings, prices and TenetScore as of How we compute thisNot investment advice

Key stats

Market cap
$40.6B
share price × the latest quarter's diluted weighted-average share count (vendor)
Tenet Score
64/100
Solid · 374 Healthcare peers

Industry: Drugs · see every company filed here →

ALEXION PHARMACEUTICALS, INC. scores 64/100. Solid. Strongest on growth and quality versus 374 Healthcare peers.

Tenet Score · vs sector

n=374
64/ 100
Solid
Fundamental composite — rates the business, not the timing.
Each metric's standing vs the company's own record is shown on the Statistics tab.
Value
40
Quality
75
Health
59
Growth
83

Factor grades

Grid rings: 25 · 50 · 75 · 100 percentile
Momentum omitted — no data yet.
ValueDQualityBHealthCGrowthBMomentum—
A grade is a label over the shown score. Value/Quality/Health/Growth are sector percentiles; Momentum ranks 12−1 return across the equity universe — a lens, never folded into the Tenet Score.
Show the math →

Price

Loading chart…
P/E
—
no P/E on file
P/B
—
no P/B on file
P/S
—
no P/S on file
ROE
5%
return on equity
Operating margin
10.4%
before interest and tax
Net margin
9.9%
of revenue kept
Current ratio
3.59
current assets to liabilities
Net debt / EBITDA
−0.2×
leverage, as the vendor nets it
EPS CAGR 5y
—
This growth figure starts in a period outside the history your plan includes.
Div yield
—
no yield on file
52-wk range
—
no 52-week range on file

The whole report, at a glance · every card is a live peek, click any to open the section

About ALEXION PHARMACEUTICALS, INC.

Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. The company offers Soliris (eculizumab), a monoclonal antibody for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), a…

Composite computed Jul 29, 2026 · peer basis: Healthcare (n=374) · every glimpse links to its full section with sources · not investment advice.

ETF exposure

held by 1 US ETFs · top wrappers by weightSee all ETFs holding ALXN →

What sector and industry is Alexion Pharmaceuticals in?

Alexion Pharmaceuticals is in the Healthcare sector and the Drugs industry.

What is Alexion Pharmaceuticals' Tenet Score?

Alexion Pharmaceuticals' Tenet Score is 64 out of 100, ranked against 374 Healthcare peers as of Jul 29, 2026.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.